Harbour BioMed Receives NMPA IND Clearance for HBM9378/SKB378 in the Treatment of Chronic Obstructive Pulmonary Disease
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Feb. 5, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody...
EARTHDAY.ORG RELEASES THE FIRST-OF-ITS-KIND LIVE TRACKER: MONITORING THE STATUS OF CLIMATE EDUCATION IN NATIONALLY DETERMINED CONTRIBUTIONS (NDCs) ACROSS THE WORLD
WASHINGTON, Dec. 9, 2024 /PRNewswire/ -- EARTHDAY.ORG, the global leader in Earth Day advocacy, observed by over one billion people each year on April 22, is proud to announce the launch of its climate education NDC Tracker —a groundbreaking tool...
CABIO Deepens Commitment to Global Markets, Aiming to Serve International Clients and Pursue Long-Term International Partnerships
FRANKFURT, Germany, Nov. 20, 2024 /PRNewswire/ -- CABIO, a high-tech enterprise underpinned by biotechnology and listed on the Science and Technology Innovation Board (stock code: 688089), unveiled its innovative product, NeoHMOs®, at the Food...